Cook Medical starts patient enrollment in heart device trial

The first patient found suitable for inclusion in the Stable dissection clinical trial was a 60-year-old male diagnosed with a type B dissection of his thoracic aorta. The patient was treated with the Cook Zenith dissection endovascular system, which is comprised of the new Cook Zenith dissection stent, used in conjunction with the Cook Zenith TX2 endovascular graft.

The company said that the TX2 stent graft repaired the primary entry tear while the bare metal dissection stents were placed to expand and support the remainder of the dissected aorta for the length of the dissection (in this case to the level of the aortic bifurcation.) The aortic repair was successful, and the patient was discharged and sent home.